Gamida Cell Stock Current Liabilities
Gamida Cell fundamentals help investors to digest information that contributes to Gamida Cell's financial success or failures. It also enables traders to predict the movement of Gamida Stock. The fundamental analysis module provides a way to measure Gamida Cell's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Gamida Cell stock.
Gamida |
Gamida Cell Company Current Liabilities Analysis
Gamida Cell's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Gamida Cell Current Liabilities | 9.55 M |
Most of Gamida Cell's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Gamida Cell is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
CompetitionIn accordance with the recently published financial statements, Gamida Cell has a Current Liabilities of 9.55 M. This is 99.45% lower than that of the Biotechnology sector and 98.24% lower than that of the Health Care industry. The current liabilities for all United States stocks is 99.88% higher than that of the company.
Gamida Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Gamida Cell's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Gamida Cell could also be used in its relative valuation, which is a method of valuing Gamida Cell by comparing valuation metrics of similar companies.Gamida Cell is currently under evaluation in current liabilities category among its peers.
Gamida Fundamentals
| Return On Equity | -11.04 | |||
| Return On Asset | -0.41 | |||
| Operating Margin | (26.80) % | |||
| Current Valuation | 70.28 M | |||
| Shares Outstanding | 132.64 M | |||
| Shares Owned By Insiders | 11.57 % | |||
| Shares Owned By Institutions | 26.48 % | |||
| Number Of Shares Shorted | 10.96 M | |||
| Price To Earning | (3.97) X | |||
| Price To Book | 117.40 X | |||
| Price To Sales | 6.44 X | |||
| Revenue | 1.78 M | |||
| EBITDA | (70.62 M) | |||
| Net Income | (63 M) | |||
| Cash And Equivalents | 55.06 M | |||
| Cash Per Share | 0.92 X | |||
| Total Debt | 82.94 M | |||
| Current Ratio | 2.57 X | |||
| Book Value Per Share | 0 X | |||
| Cash Flow From Operations | (79.12 M) | |||
| Short Ratio | 3.51 X | |||
| Earnings Per Share | (0.82) X | |||
| Target Price | 4.0 | |||
| Number Of Employees | 143 | |||
| Beta | 1.03 | |||
| Market Capitalization | 4.34 M | |||
| Total Asset | 102.19 M | |||
| Retained Earnings | (479.83 M) | |||
| Working Capital | 29.34 M | |||
| Current Asset | 56.03 M | |||
| Current Liabilities | 9.55 M | |||
| Net Asset | 102.19 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Gamida Stock
If you are still planning to invest in Gamida Cell check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gamida Cell's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |